In conclusion, this is the first study that shows PTPN11 is aberrantly expressed in multiple types of cancer and clarifies how PTPN11 expression correlates with survival of tumor patients, protein phosphorylation, TMB, MSI, MMRs, and immune cell infiltration in multiple cancers. The gene discussed is PTPN11; the disease is cancer.